BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9284375)

  • 21. Vancomycin-resistant enterococcal urinary tract infections.
    Heintz BH; Halilovic J; Christensen CL
    Pharmacotherapy; 2010 Nov; 30(11):1136-49. PubMed ID: 20973687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VRE--what every health care provider needs to know.
    Mikos-Schild S
    Todays Surg Nurse; 1998; 20(3):13-6; quiz 40-1. PubMed ID: 10026632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany.
    Wendt C; Krause C; Xander LU; Löffler D; Floss H
    J Hosp Infect; 1999 Jul; 42(3):193-200. PubMed ID: 10439991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use.
    Kolar M; Vagnerova I; Latal T; Urbanek K; Typovska H; Hubacek J; Papajik T; Raida L; Faber E
    New Microbiol; 2002 Apr; 25(2):205-12. PubMed ID: 12019727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nosocomial infection with vancomycin-dependent enterococci.
    Tambyah PA; Marx JA; Maki DG
    Emerg Infect Dis; 2004 Jul; 10(7):1277-81. PubMed ID: 15324549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
    Hagman HM; Strausbaugh LJ
    Postgrad Med; 1996 May; 99(5):60-5, 69-71. PubMed ID: 8650096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of vancomycin-resistant enterococci: one size fits all?
    Armeanu E; Bonten MJ
    Clin Infect Dis; 2005 Jul; 41(2):210-6. PubMed ID: 15983917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vancomycin-resistant enterococci.
    Chiew YF
    Ann Acad Med Singap; 1997 Nov; 26(6):808-14. PubMed ID: 9522984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of vancomycin-resistant enterococci colonization in a children's hospital.
    Christenson JC; Korgenski EK; Jenkins E; Daly JA
    Am J Infect Control; 1998 Dec; 26(6):569-71. PubMed ID: 9836840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
    Yiş R; Aslan S; Cıtak C; Değirmenci S
    Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of vancomycin-resistant enterococci isolates from human, poultry and pigs in Korea.
    Seo KS; Lim JY; Yoo HS; Bae WK; Park YH
    Vet Microbiol; 2005 Apr; 106(3-4):225-33. PubMed ID: 15778028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vancomycin-resistant enterococcus in critical care areas.
    Bryant S; Wilbeck J
    Crit Care Nurs Clin North Am; 2007 Mar; 19(1):69-75. PubMed ID: 17338952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Clin Infect Dis; 2008 Mar; 46(5):678-85. PubMed ID: 18230044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vancomycin resistant enterococci in the Netherlands].
    Leavis HL; Willems RJ; Mascini EM; Vandenbroucke-Grauls CM; Bonten MJ
    Ned Tijdschr Geneeskd; 2004 May; 148(18):878-82. PubMed ID: 15152389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.
    S D J Med; 1998 Apr; 51(4):127-32. PubMed ID: 9577692
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of avoparcin as a growth promoter and the occurrence of vancomycin-resistant Enterococcus species in Norwegian poultry and swine production.
    Kruse H; Johansen BK; Rørvik LM; Schaller G
    Microb Drug Resist; 1999; 5(2):135-9. PubMed ID: 10432274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection.
    Bates J
    J Hosp Infect; 1997 Oct; 37(2):89-101. PubMed ID: 9364258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
    Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
    Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spread of vancomycin-resistant enterococci: why did it happen in the United States?
    Martone WJ
    Infect Control Hosp Epidemiol; 1998 Aug; 19(8):539-45. PubMed ID: 9758052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.